Ironwood Appoints Dr. Jeffrey Silber Chief Medical Officer and Head of Research and Drug Development; STARS-2 Trial Initiated in June and Is Now Actively Recruiting Patients
Go back to Ironwood Appoints Dr. Jeffrey Silber Chief Medical Officer and Head of Research and Drug Development; STARS-2 Trial Initiated in June and Is Now Actively Recruiting Patients| IRONWOOD PHARMA-A (NASDAQ: IRWD) | Delayed: 4.05 -0.12 (2.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.17 | 52 Week High | $16.89 | |||
| Open | $4.14 | 52 Week Low | $7.35 | |||
| Day High | $4.16 | P/E | N/A | |||
| Day Low | $4.04 | EPS | $-2.35 | |||
| Volume | 471,667 | |||||
